Statistics for Vistin Pharma ASA (id:10441 VISTN)

Valuation metrics

Market cap

1.09B

Enterprise value

1.09B

Trailing P/E (ttm)

17.70

Forward P/E

PEG ratio

Price/Sales (ttm)

2.56

Price/Book (mrq)

3.51

Enterprise Value/Revenue

2.56

Enterprise Value/EBITDA

10.87

Overview

Shares outstanding

44.34M

Float

18.18M

Shares short

% Held by insiders

0.55%

% Held by institutions

0.14%

Average volume (10 days)

18.22K

Average volume (90 days)

Price summary

52-Week low

20.60

52-Week high

28.80

52-Week change

11.84%

Beta

0.89

50-Day moving average

26.57

200-Day moving average

23.57

Dividends and splits

Forward annual dividend rate

2.00

Forward annual dividend yield

0.08

Trailing annual dividend rate

1.00%

Trailing annual dividend yield

0.04

5-Year annual dividend yield

Payout ratio

0.90

Dividend date

Ex-dividend date

November 06th, 2024

Last split factor

2:1

Last split date

Financials

Fiscal year

Fiscal year ends

December 31th, 2023

Most recent quarter (mrq)

September 30th, 2024

Profitability

Profit margin

14.39%

Operating margin

22.74%

Operational effectiveness

Return on assets

13.34%

Return on equity

20.06%

Income statement

Revenue (ttm)

9.62

Revenue per share (ttm)

9.62

Quarterly revenue growth (yoy)

-0.30

Gross profit (ttm)

202.24M

EBITDA

86.37M

Net income to common (ttm)

61.37M

Diluted EPS (ttm)

1.39

Quarterly earnings growth (yoy)

-29.50%

Balance sheet

Total cash (mrq)

5.63M

Total cash per share (mrq)

0.13

Total debt (mrq)

8.14M

Total Debt/Equity (mrq)

2.62

Current ratio (mrq)

213.40%

Book value per share (mrq)

7.01

Cash flow

Cash flow statement

99.86M

Levered free cash flow (LFCF)

22.68M